Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma — Stella

View on ClinicalTrials.gov

Recruiting

Back to Asthma trials

Trial locations(1 site)

United States

Arthur F Gelb Medical Corporation, Lakewood, California

Key details

Sponsor

Gelb, Arthur F., M.D.

Enrollment target

~60 participants

Started

October 2007

Primary completion

June 2027

Age range

10 Years – 95 Years

Last updated October 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.